We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Destiny Pharma Plc | LSE:DEST | London | Ordinary Share | GB00BDHSP575 | ORD GBP0.01 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 18.25 | 18.00 | 18.50 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 18.25 | 18.25 | 18.25 | 232,775 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -6.5M | -0.0683 | -2.67 | 17.39M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 25/4/2024 | 20:57 | ALNC |  TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well |
| 25/4/2024 | 07:00 | UK RNS | Destiny Pharma PLC Full year results and review of strategic options |
| 08/4/2024 | 07:00 | UK RNS | Destiny Pharma PLC Notice of Full Year Results |
| 19/3/2024 | 14:47 | UK RNS | Destiny Pharma PLC Exercise of Options and Total Voting Rights |
| 31/1/2024 | 18:28 | ALNC | EARNINGS AND TRADING: STV raises holding in Two Cities Television |
| 31/1/2024 | 07:00 | UK RNS | Destiny Pharma PLC Clinical development update |
| 22/1/2024 | 07:00 | UKREG | Destiny Pharma PLC Appointment of Nominated Adviser and Sole Broker |
| 04/1/2024 | 14:07 | ALNC | Destiny Pharma seeks to capitalise on XF-73 market potential in 2024 |
| 04/1/2024 | 07:00 | UKREG | Destiny Pharma PLC Year End Business Update |
| 20/10/2023 | 12:01 | ALNC | IN THE KNOW: Destiny Pharma's XF-73 is "the real deal" amid new data |
1 Year Destiny Pharma Chart |
Intraday Destiny Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
